XM0W29ICD-11 MMS 2026-01
Antineoplastic combination estrogen
Index terms
- Antineoplastic combination estrogen
Sibling codes
XM0SU9– Steroid antineoplastic, hormone estrogenXM0ZZ0– Progestogens and estrogens, sequential preparationsXM1B43– NormethandroneXM1K26– PregnandiolXM1P34– EpiestriolXM1SH1– NoretynodrelXM26R0– Ovarian stimulantXM2GR3– Estrogen with progesteroneXM39W0– Estradiol benzoateXM3AK8– MestranolXM3HH8– QuinestrolXM3MJ7– Ovarian hormoneXM49U4– DimestrolXM4DR7– DelalutinXM4NZ9– HydroxyestroneXM5A00– Hydroxyprogesterone caproateXM5RK3– DimethisteroneXM6133– EstropipateXM6CL2– Anhydrohydroxy-progesteroneXM70N0– EstrogensXM76F9– Conjugated estrogenic substancesXM7JV9– Gonadal tissue extract femaleXM8AV0– OxendoloneXM8FT3– ProgestogenXM8WE5– HexestrolXM9HA7– ProgestogensXM9HS1– QuinestradolXM9N33– Progestogens and estrogens, fixed combinations
Foundation entity
Antineoplastic combination estrogen – http://id.who.int/icd/entity/1213347829
Part of: XM3KY1: Agents affecting genitourinary system, sex or anabolic hormones › XM6S30: Medicaments › X: Extension Codes